Charles River Financials

CRL Stock  USD 199.06  0.53  0.27%   
Based on the analysis of Charles River's profitability, liquidity, and operating efficiency, Charles River Laboratories is performing exceptionally good at this time. It has a great probability to report excellent financial results in December. At this time, Charles River's Property Plant And Equipment Net is quite stable compared to the past year. Current Deferred Revenue is expected to rise to about 253.9 M this year, although the value of Cash And Short Term Investments will most likely fall to about 173.9 M. Key indicators impacting Charles River's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Net Profit Margin0.120.11
Significantly Up
Slightly volatile
Return On Assets0.06040.0576
Sufficiently Up
Pretty Stable
Operating Income648.1 M617.3 M
Sufficiently Up
Slightly volatile
Current Ratio1.991.52
Significantly Up
Pretty Stable
Investors should never underestimate Charles River's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Charles River's cash flow, debt, and profitability to make informed and accurate decisions about investing in Charles River Laboratories.

Cash And Equivalents

222.9 Million

  
Understanding current and past Charles River Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Charles River's financial statements are interrelated, with each one affecting the others. For example, an increase in Charles River's assets may result in an increase in income on the income statement.

Charles River Earnings Geography

Charles River Stock Summary

Charles River competes with ICON PLC, Mettler Toledo, Laboratory, Waters, and IDEXX Laboratories. Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts. Charles River operates under Diagnostics Research classification in the United States and is traded on New York Stock Exchange. It employs 18600 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS1598641074
CUSIP159864107
LocationMassachusetts; U.S.A
Business Address251 Ballardvale Street,
SectorLife Sciences Tools & Services
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.criver.com
Phone781 222 6000
CurrencyUSD - US Dollar

Charles River Key Financial Ratios

Charles River Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets4.7B5.5B7.0B7.6B8.2B8.6B
Other Current Liab388.3M409.6M553.1M531.3M605.5M635.8M
Net Debt1.8B1.9B2.7B2.9B2.8B2.9B
Retained Earnings280.3M625.4M980.8M1.4B1.9B2.0B
Accounts Payable111.5M122.5M198.1M205.9M168.9M177.4M
Cash238.0M228.4M241.2M233.9M276.8M172.3M
Net Receivables514.0M617.7M642.9M752.4M780.4M819.4M
Inventory160.7M185.7M199.1M255.8M380.3M399.3M
Other Current Assets56.0M165.2M190.9M196.9M171.3M179.8M
Total Liab3.0B3.3B4.4B4.6B4.5B4.8B
Total Current Assets1.0B1.2B1.3B1.4B1.6B1.7B
Short Term Debt38.5M74.9M36.1M50.2M441.1M463.2M
Common Stock489K498K505K509K513K670.0K
Intangible Assets689.4M787.6M1.1B955.3M864.1M480.2M
Other Liab350.2M422.2M482.6M390.4M449.0M471.4M
Other Assets134.3M1.5B(47.2M)1K1.2K1.1K
Long Term Debt1.8B1.9B2.6B2.7B2.6B2.8B
Good Will1.5B1.8B2.7B2.8B3.1B3.2B
Net Tangible Assets(566.7M)(456.7M)(1.2B)(786.5M)(707.8M)(672.4M)

Charles River Key Income Statement Accounts

201920202021202220232024 (projected)
Interest Expense60.9M86.4M73.9M59.3M136.7M143.5M
Total Revenue2.6B2.9B3.5B4.0B4.1B4.3B
Gross Profit958.3M1.1B1.3B1.5B1.5B1.6B
Operating Income351.2M432.7M589.9M651.0M617.3M648.1M
Ebit351.2M524.2M588.8M732.0M718.0M753.9M
Ebitda563.1M759.1M854.3M1.0B1.0B1.1B
Cost Of Revenue1.7B1.9B2.2B2.5B2.6B2.8B
Income Before Tax304.1M447.1M480.7M623.0M581.3M610.3M
Net Income252.0M364.3M391.0M486.2M474.6M498.4M
Income Tax Expense50.0M81.8M81.9M130.4M100.9M57.3M
Minority Interest2.0M1.0M7.9M6.4M(5.6M)(5.3M)
Tax Provision50.0M81.8M81.9M130.4M137.0M99.9M
Interest Income1.5M834K74.9M780K3.9M3.8M
Net Interest Income(59.4M)(85.6M)(73.3M)(58.5M)(134.0M)(127.3M)

Charles River Key Cash Accounts

201920202021202220232024 (projected)
Change To Inventory(21.4M)(18.4M)(25.2M)(78.5M)(62.3M)(59.2M)
Change In Cash42.7M(6.9M)13.2M(5.1M)43.3M45.4M
Free Cash Flow340.4M380.0M532.0M294.9M365.4M192.8M
Depreciation198.1M234.9M265.5M303.9M314.1M329.8M
Other Non Cash Items(12.8M)(83.6M)6.0M(62.0M)(29.4M)(27.9M)
Capital Expenditures140.5M166.6M228.8M324.7M318.5M334.5M
Net Income254.1M365.3M398.8M492.6M480.4M504.4M
End Period Cash Flow240.0M233.1M246.3M241.2M284.5M173.6M
Change To Netincome22.6M73.5M23.1M(51.1M)(46.0M)(43.7M)
Investments(21.4M)(15.3M)(39.0M)(153.7M)(280.4M)(266.4M)
Change Receivables(8.3M)(85.6M)(26.6M)(150.6M)(135.5M)(128.7M)
Net Borrowings227.3M30.6M670.0M19.8M22.8M21.6M

Charles Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Charles River's current stock value. Our valuation model uses many indicators to compare Charles River value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Charles River competition to find correlations between indicators driving Charles River's intrinsic value. More Info.
Charles River Laboratories is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about  0.41  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Charles River Laboratories is roughly  2.45 . At this time, Charles River's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Charles River by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Charles River Labora Systematic Risk

Charles River's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Charles River volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Charles River Labora correlated with the market. If Beta is less than 0 Charles River generally moves in the opposite direction as compared to the market. If Charles River Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Charles River Labora is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Charles River is generally in the same direction as the market. If Beta > 1 Charles River moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Charles River Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Charles River's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Charles River growth as a starting point in their analysis.

Price Earnings To Growth Ratio

1.24

At this time, Charles River's Price Earnings To Growth Ratio is quite stable compared to the past year.

Charles River November 30, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Charles River help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Charles River Laboratories. We use our internally-developed statistical techniques to arrive at the intrinsic value of Charles River Laboratories based on widely used predictive technical indicators. In general, we focus on analyzing Charles Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Charles River's daily price indicators and compare them against related drivers.
When determining whether Charles River Labora is a strong investment it is important to analyze Charles River's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Charles River's future performance. For an informed investment choice regarding Charles Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Charles River Laboratories. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Charles River. If investors know Charles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Charles River listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.21)
Earnings Share
8
Revenue Per Share
78.97
Quarterly Revenue Growth
(0.02)
Return On Assets
0.0487
The market value of Charles River Labora is measured differently than its book value, which is the value of Charles that is recorded on the company's balance sheet. Investors also form their own opinion of Charles River's value that differs from its market value or its book value, called intrinsic value, which is Charles River's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Charles River's market value can be influenced by many factors that don't directly affect Charles River's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Charles River's value and its price as these two are different measures arrived at by different means. Investors typically determine if Charles River is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Charles River's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.